Bone Mineral Density in HIV-Negative Men Participating in a Tenofovir Pre-Exposure Prophylaxis Randomized Clinical Trial in San Francisco

BACKGROUND: Pre-exposure prophylaxis (PrEP) trials are evaluating regimens containing tenofovir-disoproxil fumarate (TDF) for HIV prevention. We determined the baseline prevalence of low bone mineral density (BMD) and the effect of TDF on BMD in men who have sex with men (MSM) in a PrEP trial in San...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Albert Y., Vittinghoff, Eric, Sellmeyer, Deborah E., Irvin, Risha, Mulligan, Kathleen, Mayer, Kenneth, Thompson, Melanie, Grant, Robert, Pathak, Sonal, O'Hara, Brandon, Gvetadze, Roman, Chillag, Kata, Grohskopf, Lisa, Buchbinder, Susan P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2011
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3163584/
https://www.ncbi.nlm.nih.gov/pubmed/21897852
http://dx.doi.org/10.1371/journal.pone.0023688

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3163584/
https://www.ncbi.nlm.nih.gov/pubmed/21897852
http://dx.doi.org/10.1371/journal.pone.0023688

Ejemplares similares